You are here: Industry Insights > Pneumagen

News List

Pneumagen Announces Neumifil is Efficacious in Established Model of COVID-19 Infection americanpharmaceuticalreview
March 12, 2021
Pneumagen announced a further milestone in the development of Neumifil™ for the treatment of COVID-19. Utilizing a hamster model of COVID-19 infection, researchers showed Neumifil was efficacious, significantly reducing clinical signs and weight loss ...
Pneumagen reports positive lab data of Covid-19 drug candidates pharmaceutical-technology
April 30, 2020
University of St Andrews spin-out Pneumagen has reported positive findings from three in-vitro studies of Neumifil and other multivalent carbohydrate binding modules (mCBMs) to prevent infection by coronaviruses, including SARS-CoV-2.
Pneumagen Announces Results from COVID-19 Infection Prevention Study americanpharmaceuticalreview
April 29, 2020
Pneumagen announced results from three separate in vitro studies into preventing coronavirus infections including SARS-CoV-2 infection.
Covid-19: MannKind, Pneumagen conduct research pharmaceutical-technology
March 19, 2020
MannKind has shifted the research and development (R&D) resources allotted for its lung diseases pipeline to help fight respiratory viral infections, including Covid-19.
Pneumagen Appoints Scientific Advisory Board americanpharmaceuticalreview
September 03, 2019
Pneumagen announced appointments to its Scientific Advisory Board (SAB), adding expertise in the areas of respiratory disease, immunology and oncology.